Bm. Ross et al., Differential alteration of phospholipase A(2) activities in brain of patients with schizophrenia, BRAIN RES, 821(2), 1999, pp. 407-413
We recently reported that the activity of a calcium-independent subtype of
phospholipase A(2) is increased in blood of patients with schizophrenia. Th
e present investigation examined whether similar changes take place in brai
n of patients with this disorder, and for comparison, in patients with bipo
lar disorder. The activity of two classes of PLA(2), calcium-stimulated and
independent, were assayed in autopsied temporal, prefrontal and occipital
cortices, putamen, hippocampus and thalamus of 10 patients with schizophren
ia, 8 patients with bipolar disorder and 12 matched control subjects. Calci
um-independent PLA(2) activity was increased by 45% in the temporal cortex
of patients with schizophrenia as compared with the controls but was not si
gnificantly altered in other brain areas. In contrast, calcium-stimulated P
LA(2) activity was decreased by 27-42% in the temporal and prefrontal corti
ces and putamen, with no significant alterations in other brain regions. Br
ain PLA(2) activity was normal in patients with bipolar disorder. Calcium-s
timulated PLA(2) activity was normal in cortex, cerebellum and striatum of
rats treated acutely or chronically with haloperidol, whereas calcium-indep
endent PLA(2) activity was decreased in striatum of chronically treated ani
mals, indicating that altered PLA(2) activity in patients with schizophreni
a is unlikely to be a direct effect of medication. Studies of the cellular
role played by PLA(2) suggest that decreased calcium-stimulated PLA(2) acti
vity, as also occurs in striatum of chronic human cocaine users, may be due
, in part, to increased dopaminergic activity in the disorder, whereas incr
eased calcium-independent PLA(2) activity may be related to abnormal fatty
acid metabolism and oxidative stress in schizophrenia. (C) 1999 Elsevier Sc
ience B.V. All rights reserved.